PMC4477113_01
OCT scan of the patient with chronic central serous chorioretinopathy before SDM treatment. General retinal thickening present in the fovea together with small PED. Subretinal fluid present in the superior part of the macula.
CRIOPM2015-813414.001.jpg
PMC4477113_01_CRIOPM2015-813414.001.jpg
fig1
On the OCT scan there was retinal thickening present in the foveal region, as well as subretinal fluid outside the foveal area (Figure 1).
OCT scan 2 days after SDM treatment: large amount of subretinal fluid present as well as persistent small PED. Increase in the thickening of the sensory retina.
CRIOPM2015-813414.002.jpg
PMC4477113_01_CRIOPM2015-813414.002.jpg
fig2
On SD OCT there was significant amount of subretinal fluid present in the macular area (Figure 2).
Fundus autofluorescence image taken 2 days after treatment. In the central part, visible alterations of the RPE with pigmentary changes (spots of hypofluorescence) and thermal RPE reaction (spots of hyperfluorescence). On the midperiphery, older retinal changes can be seen, due to previous serous fluid accumulation.
CRIOPM2015-813414.003.jpg
PMC4477113_01_CRIOPM2015-813414.003.jpg
fig3
Autofluorescence image showed punctate areas of hyperfluorescence referring to multispot laser pattern used for the treatment (Figure 3).
OCT scan a month after SDM treatment. Resorption of the subretinal fluid and slight reduction of the retinal thickening in comparison to the scan taken before laser treatment.
CRIOPM2015-813414.004.jpg
PMC4477113_01_CRIOPM2015-813414.004.jpg
fig4
BCVA was back to 0,63:same as before laser treatment:and CRT was slightly reduced as compared to the state before laser therapy (Figure 4).